Shiny K. Kajal/LinkedIn
Mar 24, 2026, 02:55
Shiny K Kajal: FFP as a Targeted Coagulation Therapy
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
”Post 27- FFP is not just ‘something to hang.’
It’s not a fluid.
It’s not a reflex.
It’s not routine.
It is targeted coagulation therapy.
If there’s no active bleeding or significant coagulopathy,
ask yourself – what exactly are you treating?
Because every unit carries risk:
TRALI. TACO. Allergic reactions. Infection.
More plasma ≠ better outcomes.
Correction ≠ clinical benefit.
Transfuse with purpose.
Dose appropriately.
Treat the patient – not the comfort of doing something.”
Shiny K. Kajal/LinkedIn
Stay updated with Hemostasis Today.
-
Mar 24, 2026, 02:58Pierre Sabouret: The Additive Value of CV Imaging in CVR Assessment
-
Mar 24, 2026, 02:53Ney Carter Borges: Circadian Disruption and Melatonin Deficiency as Cardiovascular Risk Factors
-
Mar 24, 2026, 02:52Hamid Noori: Blood Transfusion Types at a Glance
-
Mar 24, 2026, 02:50Jay Herath: Fitusiran Advancing Hemophilia Care Beyond Factor Replacement
-
Mar 24, 2026, 02:43Kathaleen Schnur: Strong Representation from the Hemophilia Center of Western Pennsylvania at THSN 2026
-
Mar 24, 2026, 02:36Rana Jaber: Uncovering Cardiovascular Harm in Waterpipe Smoking
-
Mar 23, 2026, 17:57Prashant Mukkannavar: Making Pain Assessment Accessible and Culturally Relevant for Stroke Survivors
-
Mar 23, 2026, 17:52Avril Mansfield: Does Walking Asymmetry After Stroke Increase the Risk of Lateral Instability and Falls?
-
Mar 23, 2026, 17:47Katherine Caster: Celebrating The Impact and Continued Leadership of AHA In The Fight Against Heart Disease and Stroke